NCT01690169
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +5 more
- Locations
-
- Novo Nordisk Investigational Site Nottingham, United Kingdom
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
2,679 public trials
155 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT01492153
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
- Locations
-
- Novo Nordisk Investigational Site Jakarta, Indonesia
NCT01098539
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +10 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Gulf Shores, Alabama, United States
- GSK Investigational Site Huntsville, Alabama, United States
- GSK Investigational Site Toney, Alabama, United States
NCT01492218
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
- Locations
-
- Novo Nordisk Investigational Site Manila, Philippines
NCT00871416
- Conditions
- Autoimmune Diseases, Delivery Systems, Diabetes, +8 more
- Locations
-
- Novo Nordisk Investigational Site Aarhus, Denmark
NCT00494884
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Investigative Site Bochum, Germany
Completed
Efficacy and Safety of Vildagliptin as add-on Therapy to Metformin in Patients With Type 2 Diabetes
NCT01497522
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Investigative Site Fukuoka, Japan
- Novartis Investigative Site Fukuoka, Japan
- Novartis Investigative Site Kitakyushu, Fukuoka, Japan
- Novartis Investigative Site Kurume, Fukuoka, Japan
Completed
Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects
NCT01572753
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +5 more
- Locations
-
- Novo Nordisk Investigational Site Berlin, Germany
NCT01467375
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Broadmeadow, New South Wales, Australia
- Novo Nordisk Investigational Site Parkville, Victoria, Australia
- Novo Nordisk Investigational Site Ashford, Australia
- Novo Nordisk Investigational Site Auchenflower, Australia
NCT01650129
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Tokyo, Japan